Click to view this email in a browser  |  Forward this message to a friend
A complimentary accredited Webinar:
The Journey to Realizing the Promise of Precision Medicine
Date: Tuesday, October 17, 2017
Time: 1:00 - 2:00 PM EDT
This webinar is produced by Whitehat Communications
and sponsored by Fisher HealthCare.
Gray line 300x1 3
Fisher Healthcare Logo_2c_jpg
Currently, clinical labs are doing sequential, single-analyte testing in oncology which exhausts precious patient samples and extends the turnaround time to results. Clinicians can wait for as long as two to three weeks to get a result. And, if the sample is insufficient for molecular testing, patients can be subject to expensive and painful rebiopsies. Pathologists and other clinicians need a better, faster way to consolidate their molecular testing into a single assay and get results within a week.

This webinar will show how Next-Generation Sequencing (NGS) is helping labs save precious samples and provide rapid results. It will review the updates on the NCI-MATCH clinical trial for adult cancers and the development of a gene panel specific to pediatric cancers, and it will discuss a laboratory's implementation of next-generation sequencing for cancer clinical research.
This webinar will:
  • Review the updates on the NCI-MATCH clinical trial for adult cancers and the development of a gene panel specific to pediatric cancers
  • Analyze the effects of next-generation sequencing on the speed of results from the clinical/pathology lab to oncologists to minimize the need for a painful and expensive rebiopsy
  • Discuss a laboratory's implementation of next-generation sequencing for cancer clinical research
Gray line 300x1 2
The presenters
  Tim-Triche-Headshot Timothy Triche, MD, PhD
Pathologist; Co-Director, Center for Personalized Medicine Program (CPM)
Professor of Pathology and Pediatrics, USC Keck School of Medicine

Dr. Timothy Triche is the founding Director for the Children’s Hospital Los Angeles Center for Personalized Medicine. He previously served as Chief of the Department of Pathology and Laboratory Medicine for over 20 years. He is also Professor of Pathology and Pediatrics at the Keck School of Medicine of the University of Southern California. At Children’s Hospital, his research is focused on high-risk childhood cancer, including molecular diagnostics and nanoparticle therapeutics, as part of an overall focus on ‘precision’ or ‘personalized’ treatment of childhood cancer. He is the author of over 250 peer reviewed publications and has received over $40 million in NIH or equivalent funding as PI, and has been a co-PI or co-investigator on over $100 million of other grants. He has also received over $5 million of private research funding. 
Mickey-Williams-125x163 Mickey Williams, Ph.D.
Director, Molecular Characterization Laboratory, National Cancer Institute

Mickey Williams, Ph.D., directs the Molecular Characterization Laboratory, established by the National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis (DCTD), to focus on development of state of the art genomic technologies for clinical research. Laboratory goals are to assist in the development and application of well-characterized and validated clinical assays to support cancer patient management. One of several ongoing projects is the development and implementation of massively parallel sequencing assays for selection of patients for early stage clinical trials. Dr. Williams is Co-Scientific Principal Investigator for the NCI-MATCH Trial. He co-chairs the clinical laboratory network supporting this large precision medicine trial. Dr. Williams has published over 50 manuscripts and is an inventor on over 30 issued U.S. Patents. He received his Ph.D. from the University of Virginia.
  Continuing education credit:
  • 1 P.A.C.E.® credit-hour will be provided for this complimentary basic level program.
    Whitehat Communications is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.
  • This session is approved for 1 Florida Laboratory CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563
This webinar is sponsored by Fisher HealthCare
Fisher Healthcare Logo_2c_jpg
©2017 Fisher HealthCare

Click to view this email in a browser

If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe

Whitehat Communications
2220 Ivy Rd
Charlottesville, Virginia 22903